
XORTX Pharma Corp. Announces Publication of Phase II Proof of Concept Clinical Trial in Adolescent Hypertension.
CALGARY- Nov 29, 2012 – XORTX Pharma Corp. wishes to congratulate Dr. Beth Soletsky and Dr Daniel Fieg on the successful completion of their phase II clinical trial in adolescent hypertension entitled “Uric Acid Reduction Rectifies Prehypertension in Obese Adolescents” and publication of results in the prestigious journal Hypertension, 2012;60:1148.
› Read more